TIAP Staff

MI’s Elizabeth Monier-Williams to speak at TedxWaterlooWomen December 1

November 27, 2012
Susanne Staer
Media Coverage

Elizabeth Monier-Williams, marketing and communications manager — **Elizabeth Monier-Williams**, marketing and communications manager at MaRS Innovation.

Elizabeth Monier-Williams, MaRS Innovation’s marketing and communications manager, is giving a Tedx talk at the TedxWaterlooWomen event in Waterloo, Ontario, on December 1.

Read the Kitchener-Waterloo Record’s summary story and their curated highlights from the event’s social chatter on Storify.

The event, hosted by the Centre for International Governance Innovation (CIGI), will include a live stream of talks from the second annual TedxWomen conference in Washington, D.C., along with talks by local speakers, including Monier-Williams, for the Waterloo audience.

OtoSim featured in Health Research & Innovation, receives B Corp Designation (video)

November 23, 2012
Susanne Staer
Media Coverage

OtoSim Inc., a MaRS Innovation spin-of company, was featured along with MaRS Innovation in the Autumn 2012 edition of Health Research & Innovation magazine. The article by Tim Wilson is…

We’ve refreshed our website: Beta version now live

Refreshed MaRS Innovation website — We’ve refreshed our layout and added new features.

Welcome to the beta version of the MaRS Innovation website.

We have refreshed the site’s design to make better use of its existing functionality while showcasing our projects.

The new design includes these additions and changes:

ClevrU partners with Schulich School of Business professors to target online education market

MaRS Innovation and York University’s commercialization office support new partnership

Students in China interact with the ClevrU platform. Photo courtesy of ClevrU Inc.

In the age of ITunes, videotaping lectures or converting existing textbooks into e-books won’t make you the market leader in online education.

Thanks to a new partnership between ClevrU, and NewMindsets Inc., facilitated by MaRS Innovation and York University’s commercialization office, Canadian technology and content promises to establish the second-generation online learning standard for millions of students worldwide.

U of T, MaRS Innovation Collaborate to Launch Incubator for Student Software Companies

October 1, 2012
Susanne Staer
CoursePeer

Hadi Aladdin (left) and Marwan Aladdin, U of T graduates and the founders of CoursePeer. — **Hadi Aladdin** (left) and **Marwan Aladdin**, U of T graduates and the founders of **CoursePeer**, one of six UTEST companies.

TORONTO, ON – A new program that provides nascent software companies with start-up funds, work space, mentoring and business strategy support, was launched today by the University of Toronto and commercialization partner MaRS Innovation, with support from the MaRS Discovery District.

TechVibes has a profile page for UTEST and covered CoursePeer as part of their students start-ups series.

The new program, called University of Toronto Early Stage Technology (UTEST), is part of a growing ecosystem of incubators and commercialization support services at U of T, including the newly-launched Banting and Best Institute. UTEST is unique among campus incubators in that its companies receive start-up funds—$30,000 each in this inaugural year—and because it accepts companies in the very earliest stages of idea generation, before they’re ready for traditional incubators.

Business Without Borders highlights ScarX Therapeutics’ Chinese co-development partnership

September 27, 2012
Susanne Staer
Industry Partners

ScarX Therapeutics, a spin-off company created by MaRS Innovation and The Hospital for Sick Children (SickKids), was profiled by Business Without Borders on September 25, 2012.

Sean Fine‘s article examines the strategic funding partnership MI pursued with NovoTek Therapeutics Inc. (NovoTek) in China to develop the anti-scarring cream, which was discovered by researchers at SickKids.

A multibillion-dollar market may await ScarX, a Toronto biomedical start-up, but first it had to figure out how to finance the development of its unique cream that reduces scarring after surgery.

Its answer to the shortage of Canadian venture capital in life sciences turned out to be a partnership with a drug company in China.

VP Joel Liederman’s Financial Post article on mitigating innovation risk

September 23, 2012
Susanne Staer
Media Coverage

Joel Liederman, vice-president (physical sciences) — Joel Liederman, MI’s vice-president of business development and physical sciences

MaRS Innovation’s Vice-President of Business Development and Physical Sciences Joel Liederman, has published an article in the Financial Post about strategies to mitigate risk within the innovation space.

The article, titled “Innovation Success Means Mitigating Risk,” is featured in the newspaper’s Productive Conversations section.

OtoSim CEO Andrew Sinclair: When entering the market, expect the unexpected

Andrew Sinclair, CEO of OtoSim Inc. and a senior director at MaRS Innovation, describes some of the unexpected twists and turns OtoSim has weathered in bringing their product to market in…

Huffington Post Canada interviews Raphael Hofstein about Canadian venture capital shortage

August 20, 2012
Susanne Staer
Media Coverage

Raphael Hofstein, president and CEO of MaRS Innovation, was interviewed by Huffington Post Canada business reporter Rachel Mendleson for an article about Canada’s innovation gap and the shortage of Canadian venture capital:

One of the best ways to [raise venture capital], said Raphael Hofstein, President and CEO of Toronto-based MaRS Innovation, is to increase government investment, a lesson he learned while helping to create a life sciences early-stage fund in Israel several years ago.

“Everybody told us — institutions, industry — that they will not participate unless government has a piece of the pie. So governments have to participate, certainly in the early stage,” he said.

VP Joel Liederman: MaRS Innovation, Canadian Research and the Commercialization Test

August 13, 2012
Susanne Staer
Media Coverage

Joel Liederman, vice-president of business development and physical sciences — Joel Liederman, MI’s vice-president of business development and physical sciences

Joel Liederman, MaRS Innovation’s vice-president of Business Development and Physical Sciences, was quoted in a National Post article, published August 13, probing whether Canadian research is passing the commercialization test.

Here’s an excerpt:

While academics have often been accused of being disconnected from the real world and consuming themselves with the theoretical, it’s hard to imagine they would be able to get away with squandering funding dollars on things that make them go hmmm, particularly in light of the hyper focus on fiscal prudence.

Indeed, those who are intimately involved in attempting to bridge the commercialization gap agree that the old system of leaving university professors to their own devices had long ago been shelved in favour of a more judicious approach.

Joel Liederman, vice president of Business Development and Physical Sciences at MaRS Innovation, says there’s no doubt that much of the R&D being performed in Canada never makes it past the patent stage, but not because its origins were founded on theory instead of commercial need.

MI’s Elizabeth Monier-Williams to speak at TedxWaterlooWomen December 1

We’ve refreshed our website: Beta version now live

ClevrU partners with Schulich School of Business professors to target online education market

MaRS Innovation and York University’s commercialization office support new partnership

U of T, MaRS Innovation Collaborate to Launch Incubator for Student Software Companies

Business Without Borders highlights ScarX Therapeutics’ Chinese co-development partnership

VP Joel Liederman’s Financial Post article on mitigating innovation risk

OtoSim CEO Andrew Sinclair: When entering the market, expect the unexpected

Huffington Post Canada interviews Raphael Hofstein about Canadian venture capital shortage

VP Joel Liederman: MaRS Innovation, Canadian Research and the Commercialization Test

Quick Links

Contact Us